Related Experiment Video

Updated: Apr 15, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.6K

The need for treatment interruption studies and biomarker identification in the search for an HIV cure

Jonathan Z Li1, Davey M Smith, John W Mellors

  • 1aBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts bUniversity of California, San Diego, La Jolla, California cUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

AIDS (London, England)
|April 15, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.3K

Related Experiment Videos

Last Updated: Apr 15, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.6K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.3K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

375
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
375

Articles linked to this work by shared authors, journal, and citation graph.

Discontinuing contact precautions for COVID-19: the science says its time.

Infection control and hospital epidemiology·2026

Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19.

Pathogens & immunity·2026

Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution.

Microbiology spectrum·2026

Mapping opioid exposure through prescription data and postmortem analysis of opioid drugs in multiple tissues.

British journal of clinical pharmacology·2026

A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2.

NPJ vaccines·2026

Cell-type specific impact of opioid use disorder and HIV on the human forebrain and cerebellum.

bioRxiv : the preprint server for biology·2026

Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

AIDS (London, England)·2026

Cancer incidence and risk factors among people with HIV in REPRIEVE.

AIDS (London, England)·2026

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

AIDS (London, England)·2026

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

AIDS (London, England)·2026

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

AIDS (London, England)·2026

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

AIDS (London, England)·2026

Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

IL-21 boosts T cell-therapy efficacy for solid tumors by enhancing mitochondrial Ca2+-mediated motility of effector CD8+ T cells.

Cancer immunology research·2026

Removal of boxed warning for menopausal hormone therapy: What nurses need to know.

Nursing·2026

Fruquintinib: Mechanism of Action, Clinical, and Translational Science.

Clinical and translational science·2026

The RNA-binding protein Psc1 functions downstream of the NDR/LATS kinase Cbk1 to modulate CO2 tolerance in Cryptococcus neoformans.

mBio·2026

In the wisdom of Odin: modular architecture, receptor trafficking and therapeutic implications.

Expert opinion on therapeutic targets·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us